AbCellera Biologics Menopause Drug Data Shows 'New Efficacy Benchmark'
AbCellera reports positive Phase 2 clinical trial results for ABCL635, a single-dose treatment for menopausal hot flashes.
AbCellera tested a new medicine for hot flashes and got good results in an early-stage study. When a company shows that its medicine works well, people watch to see if it might become a real product doctors can use someday.
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.